ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "neutrophils"

  • Abstract Number: 0078 • ACR Convergence 2025

    Citrullinated Serum Albumin Is Not an Autoantigen in Rheumatoid Arthritis

    Farheen Sultan Shaikh, cecilia mustelin, Xiaoxing Wang and Tomas Mustelin, University of Washington, Seattle, WA

    Background/Purpose: Autoantibodies against citrullinated proteins (ACPAs) are diagnostic of rheumatoid arthritis (RA), an autoimmune disease primarily affecting synovial joints. Proteomic analyses have identified human serum…
  • Abstract Number: 2581 • ACR Convergence 2025

    From Skin to Kidney: Neutrophil-Mediated Crosstalk Links Cutaneous Injury to Renal Inflammation and Vascular Remodeling in Lupus

    Angelique Cortez1, Lindsay Mendyka2, Paola Garcia3, Elizabeth Nowak1, Fred Kolling4, Lucas Salas1, Christopher Burns5, Andrea Fava6 and Sladjana Skopelja-Gardner7, 1Dartmouth College, Lebanon, NH, 2Dartmouth College, Lyme, NH, 3St. Mary's University, San Antonio, TX, 4Geisel School of Medicine at Dartmouth, Lebanon, NH, 5Dartmouth Health, Lebanon, NH, 6Johns Hopkins University, Baltimore, MD, 7Dartmouth Geisel School of Medicine, Lebanon, NH

    Background/Purpose: The majority of SLE patients are sensitive to ultraviolet light (UV), which can lead to local and systemic inflammation, including lupus nephritis (LN) flares.…
  • Abstract Number: 0951 • ACR Convergence 2025

    Epidermal IFNκ Increases Circulating and Cutaneous Monocytes in a C57/Bl6 Overexpression Mouse Model

    Patrick O'Brien, Benjamin Klein, Deborah Colesa and J. Michelle Kahlenberg, University of Michigan, Ann Arbor, MI

    Background/Purpose: Lupus is a heterogeneous inflammatory autoimmune disease affecting a variety of organs, including skin manifestations such as photosensitivity and cutaneous lesions. The skin of…
  • Abstract Number: 0067 • ACR Convergence 2025

    Identification of Neutrophil Extracellular Traps in Explanted Human Lungs with Rheumatoid Arthritis-related Interstitial Lung Disease

    Amara Seng1, Kensuke Suga2, Diana Tran3, Anvita Singaraju4, Tanyalak Parimon5, Youn Jung Choi6, Justyna Fert-Bober7, Jon Giles8, Peter Chen5 and Nunzio Bottini9, 1Cedars-Sinai Medical Center, Los Angeles, CA, 2Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Beverly Hills, CA, 3Cedars Sinai Medical Center, La Cañada Flintridge, CA, 4Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, 5Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 6Kao Autoimmunity Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 7Smidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 8Cedars Sinai Medical Center, Los Angeles, CA, 9Cedars Sinai Medical Center, Beverly Hills, CA

    Background/Purpose: Symptomatic rheumatoid arthritis-related interstitial lung disease (RA-ILD) is prevalent in about 10% of patients with RA and confers a higher mortality compared with RA…
  • Abstract Number: 2580 • ACR Convergence 2025

    Estrogen Modulates Neutrophil Biology: Implications for Autoimmunity

    William Ambler1, Eduardo Patino-Martinez1, Gustaf Wigerblad1, Shuichiro Nakabo2, Jorge Romo-Tena3, Norio Hanata4, James Simone1, Stephen Brooks1, Kan Jiang5, Hong-wei Sun1, Faiza Naz6, Shamima Islam6, Gustavo Gutierrez-Cruz1, Stefania Dell'Orso1, Anshu Deewan7, Vicky Chen7, Paul Schaughency8, Carmelo Carmona-Rivera4, Sarfaraz Hasni1, Veronica Gomez-Lobo9 and Mariana Kaplan4, 1NIH/NIAMS, Bethesda, MD, 2NIAMS, NIH, Bethesda, MD, 3Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 4Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, MD, 5Biodata Mining and Discovery Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, Bethesda, 6National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), National Institutes of Health (NIH), Bethesda, MD, 7NIH/NIAID, Bethesda, MD, 8NIAID, NIH, Bethesda, MD, 9NIH/NICHD, Bethesda, MD

    Background/Purpose: Neutrophils are essential for inflammation and host defense against infections. Our group has previously highlighted their key roles in the pathogenesis of diseases that…
  • Abstract Number: 0928 • ACR Convergence 2025

    Radiolabelled anti-citrullinated histone antibody CIT-013 as a tool to visualize NET rich inflamed joints in a collagen induced arthritic mouse model

    Annemarie Kip1, Daphne Dorst2, Birgitte Walgreen2, Monique Helsen2, Eric meldrum1, Renato Chirivi1 and Marije Koenders2, 1Citryll BV, Oss, Netherlands, 2RadboudUMC, Nijmegen, Netherlands

    Background/Purpose: Neutrophil Extracellular Traps (NETs) contribute to the pathophysiology of multiple immune-mediated inflammatory diseases including Rheumatoid Arthritis (RA), and may be promising therapeutic targets. The…
  • Abstract Number: 0059 • ACR Convergence 2025

    Formyl Peptide Receptor 1 (FPR1) Influences Arthritis Severity in a Sex- and Compartment-Specific Manner

    Ryan D. Stultz1, Payton Hermanson2, Noelle Mullin3, Simeon Ramsey3 and Christian Lood2, 1University of Washington, Division of Rheumatology, Seattle, WA, 2University of Washington, Seattle, WA, 3Pfizer Inc., Cambridge, MA

    Background/Purpose: Rheumatoid arthritis (RA) is a chronic, systemic inflammatory disease that disproportionately affects females over males (3:1). Although sex-based immune differences have been documented, particularly…
  • Abstract Number: 2579 • ACR Convergence 2025

    Mutant COPA Permits Aberrant NETosis and Exacerbates Autoimmune Lung Disease

    Richard Moore1, Lihong Huo1, Colin Koziel1, Barry Stripp2, Tiphanie Vogel3, Daniel Wallace4 and Caroline Jefferies5, 1Cedars-Sinai, Beverly Hills, CA, 2Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 3Baylor College of Medicine, Houston, TX, 4Cedars Sinai Medical Center, Studio City, CA, 5Cedars-Sinai Medical Center, Beverly Hills, CA

    Background/Purpose: COPA syndrome is an autosomal dominant disease caused by missense mutations within the COPA gene. Typical onset begins during childhood with patients developing lung…
  • Abstract Number: 0917 • ACR Convergence 2025

    Synovial Tissue Neutrophils are Associated with Disease Activity and Early Remission in Rheumatoid Arthritis

    Annabelle Small1, Vincent Wong2, Christopher Altmann1, Helen Weedon3, Malcolm Smith4, Susanna Proudman5 and Mihir Wechalekar6, 1Flinders University, Bedford Park, South Australia, Australia, 2College of Medicine and Public Health, Bedford Park, South Australia, Australia, 3Flinders University of South Australia, Bedford Park, South Australia, Australia, 4Flinders University, Adelaide, South Australia, Australia, 5Royal Adelaide Hospital and University of Adelaide, Medindie, South Australia, Australia, 6Flinders Medical Centre and Flinders University, Bedford Park, South Australia, Australia

    Background/Purpose: Neutrophils drive local pathology of rheumatoid arthritis (RA) in the synovial tissue (ST) through local production inflammatory mediators, cytokines, and extracellular traps. However, despite…
  • Abstract Number: 2425 • ACR Convergence 2025

    Neutrophil Transcriptomics in SLE: Exploring Intrinsic, Ex Vivo Adaptation, and CAR-T Cell Therapy-Induced Changes

    Ehsan Dehdashtian1, Stefania Gallucci2, Guangnan Hu3, Dominic Borie4 and Roberto Caricchio5, 1UMass Chan Medical School, Worcester, MA, 2Temple University School of Medicine, Worcester, MA, 3UMass Chan School of Medicine, Worcester, MA, 4Kyverna Therapeutics, Emeryville, CA, 5University of Massachusetts Chan Medical School, Worcester, MA

    Background/Purpose: Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by dysregulation of the adaptive and innate immune systems. Neutrophils, key players in innate immunity,…
  • Abstract Number: 0665 • ACR Convergence 2025

    Infusion-Related Reactions (IRRs) and Hematologic Events Associated With Obinutuzumab in Lupus Nephritis: A Secondary Analysis of a Phase III Trial

    Richard Furie1, Teresa Baczkowska2, Amit Saxena3, Imran Hassan4, Bongin Yoo5, Ben Lanza6, Himanshi Sehgal7, Frederic Boissard7, Jay Garg5, Thomas Schindler7, Elsa Martins7, William Pendergraft5 and Brad Rovin8, 1Division of Rheumatology, Northwell Health, Great Neck, NY, 2Department of Transplantation Medicine, Nephrology and Internal Medicine, Medical University of Warsaw, Warsaw, Poland, 3Division of Rheumatology, Department of Medicine, NYU Grossman School of Medicine, New York, NY, 4Hoffmann-La Roche Ltd, Mississauga, ON, Canada, 5Genentech, Inc., South San Francisco, CA, 6Roche Products Ltd, Welwyn Garden City, United Kingdom, 7F. Hoffmann-La Roche Ltd, Basel, Switzerland, 8The Ohio State University, Columbus, OH

    Background/Purpose: The REGENCY (NCT04221477) trial demonstrated superior efficacy of obinutuzumab and standard therapy (OBI+ST) over placebo and ST (PBO+ST) in patients (pts) with active lupus…
  • Abstract Number: 2231 • ACR Convergence 2025

    Inverse Correlation Between Neutrophil Activation and Rheumatoid Factor Concentrations in Rheumatoid Arthritis (RA)

    Anne-Christine Bay-Jensen1, Dovile Sinkeviciute2, Christian Thudium2, shu Sun1, Mathilde Christensen1, Morten Karsdal1, marta Alexdottir1 and Joachim mortensen1, 1Nordic Bioscience A/S, Herlev, Denmark, 2Nordic Bioscience, Herlev, Denmark

    Background/Purpose: Neutrophils are crucial in fibro-inflammatory diseases like Crohn's disease (CD) and rheumatoid arthritis (RA), but their biomarkers are better established in CD than in…
  • Abstract Number: 0609 • ACR Convergence 2025

    Neutropenia in SLE: a Retrospective Cohort Study of Etiologies, Severity, Management, and Infection Outcomes

    Eleni Papachristodoulou1 and Vasileios Kyttaris2, 1Mount Auburn Hospital, Harvard Medical School, Cambridge, MA, 2Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA

    Background/Purpose: Neutropenia is a known hematologic manifestation of SLE, yet its clinical implications remain poorly defined. We conducted a retrospective study to characterize the frequency,…
  • Abstract Number: 2078 • ACR Convergence 2025

    Neutrophil Extracellular Traps from Patients with Idiopathic Inflammatory Myopathies Induce Interferogenic Responses in Macrophages and Myeloid Dendritic Cells

    Yatzil Reyna Juárez1, Jennifer Tiaré Balderas Miranda2, Beatriz Alcalá Carmona3, María José Ostos Prado4, karina santana5, Diana Gómez-Martín6 and Jiram Torres Ruiz7, 1Instituto Politècnico Nacional, Tultitlán de Mariano Escobedo, Mexico State, Mexico, 2Universidad Nacional Autónoma de México, Coyoacán, Federal District, Mexico, 3INCMNSZ, Cdmx, Distrito Federal, Mexico, 4Instituto Nacional De Ciencias Médicas Y Nutrición Salvador Zubirán, Mexico City, Distrito Federal, Mexico, 5INCMNSZ, Ciudad de México, Federal District, Mexico, 6INCMNSZ, Mexico city, Federal District, Mexico, 7INCMNSZ, Mexico, Federal District, Mexico

    Background/Purpose: Dermatomyositis (DM) and anti-synthetase syndrome (AS) are idiopathic inflammatory myopathies (IIM) with perifascicular pathology involving vasculopathy, macrophages, dendritic cells and an overexpression of interferon-stimulated…
  • Abstract Number: 0857 • ACR Convergence 2025

    CD14-dependent MAP kinase signaling is required for pathogenic neutrophil extracellular trap formation in APS

    Thalia Newman1, NaveenKumar Somanathapura1, Chao Liu2, Srilakshmi Yalavarthi1, Pooja Kapoor1, Ajay Tambralli1, Jacqueline Madison1, Yu (Ray) Zuo1 and Jason S. Knight1, 1University of Michigan, Ann Arbor, MI, 2University of Michigan, Superior Charter Twp, MI

    Background/Purpose: Antibodies targeting beta-2-glycoprotein I (anti-β2GPI) promote inflammation and thrombosis in antiphospholipid syndrome (APS). It has been shown that anti-β2GPI activate neutrophils through Toll-like receptor…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 13
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology